#ACR21 [Dr Pooni] #Telemedicine #Pediatrics providers felt PE was worsened BUT msk exam was the MOST reliable. @endocrine_witch @millennialpedia https://t.co/3FGCyBIxB2 https://t.co/fgwdk0WXKm

• Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic | Pe…

Handy overview of Jak/STAT pathways in rheumatic diseases and available inhibitors (Dr. Joost Swart). Happening now in the Pediatrics Hub (New Therapies & Biologic Safety in Pediatric Rheumatology​). #ACR21 #pedsrheum https://t.co/i4bYr4GKOP

#ACR21 #pedsrheum I say it counts! I mean, at the end of the day, these are all just pictures of food on the internet, right? #ACRBakeAnythingChallenge https://t.co/bVQuealWWX

• Janet Pope on Twitter: "?Child’S play #ACRBakeAnythingChallenge. Caution m…

New dimensions in cellular immunology. Great session, some which I understood. Kids with #JIA have more cytolytic pathway missense - some leads to macrophage activation syndrome #MAS Low NK cells in Juvenile Dermatomyositis. 9T112 #ACR21 @RheumNow https://t.co/5lUkqr65UM

Can you stop monitoring eyes in + ANA and/or pauciarticular pt who becomes an adult if no uveitis ever, in last 5 yrs, etc. When can we stop looking? #AVR21 @RheumNow https://t.co/1Ml1BuJD7Y

• Sheila Angeles-Han on Twitter: "Adults with #JIA #uveitis are still affect…

#ACR21 #pedsrheum Risk factors for poor outcomes: delay to diagnosis, poor access to therapy, poor access to care https://t.co/SlFyav5KV6

Please don’t miss MISC (pronounced Miss C)=multisystem inflammatory syndrome. Pediatric syndrome post #SARSCoV2 infection. May go w macrophage activation syndrome (MAS) w distinct proteomics signature. Potentially v poor outcomes. Need to dx and treat #ACR21 abst0961 @RheumNow https://t.co/uaBbUdg3lt

#ACR21 #pedsrheum juvenile localized scleroderma Polypositive profile 3 or more autos correlated with more severe skin score, more activity https://t.co/vVXV4jjLvG